Citrulline antibody is present in most patients with rheumatoid arthritis. It is used in the diagnosis of rheumatoid arthritis when evaluating patients with unexplained joint inflammation. A test for citrulline antibodies is most helpful in looking for the cause of previously undiagnosed inflammatory arthritis when the traditional blood test for rheumatoid arthritis, rheumatoid factor, is not present. Citrulline antibodies have been felt to represent the earlier stages of rheumatoid arthritis in this setting.
The anti-CCP test should be useful in identifying patients with early seronegative polyarthritis as individuals with rheumatoid arthritis when the test is positive.
Potential false positives in some tested cases:
- Parvoviral Arthropathy, 5%of cases
- SLE, 2.5% of cases
- Early Synovitis
- Hepatitis C
- Seronegative Inflammatory Arthropathy
- Polymyalgia Rheumatica
- Sarcoidosis
- Spondyloarthropathy 0/19
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Reiter's Syndrome
- Inflammatory Bowel Disease with Arthritis
- Undifferentiated Spondyloarthropathy
- Fibromyalgia
- Remitting Seronegative Symmetrical Synovitis with Pitting Edema
Results should be used in conjunction with other clinical findings to make a diagnosis of rheumatoid arthritis
Reference values (ELISA)
dependent on method |
< 20 EU |
negative |
20 – 39 EU |
weak positive |
40 - 59 EU |
moderate positive |
3 69 EU |
strong positive |
|